AK

Akshay Kumar Mandal

Active Director Managing Director DIN 09538611
DIN 09538611 First appointment Mar 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Akshay Kumar Mandal

Data last updated:

Akshay Kumar Mandal is a Managing Director at Next Science Pathology Private Limited (since 2022). The company operates in Non-Profit Organizations.

DIN 09538611
Primary Designation Managing Director
Industry Non-Profit Organizations
First Appointment 17 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director17 Mar 20222022Active

Board colleagues of Akshay Kumar Mandal

NameDINCompanyDesignation
Prity Mal09538610Next Science Pathology Private LimitedDirector

Directorship timeline

Open interactive timeline →
Next Science Pathology Private Limited
Premium access

Shareholding and investment profile for Akshay Kumar Mandal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Kumar Mandal

Akshay Kumar Mandal currently holds 1 directorship: Next Science Pathology Private Limited (Managing Director, since 17 Mar 2022).

Akshay Kumar Mandal was first appointed on 17 Mar 2022 as Managing Director at Next Science Pathology Private Limited.

The current boards of Akshay Kumar Mandal's companies include Prity Mal (Next Science Pathology Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available